Recursion Pharmaceuticals Inc Cl A (RXRX)
5.61 x 41 5.62 x 2
Pre-market by (Cboe BZX)
5.81 -0.16 (-2.68%) 03/28/25 [NASDAQ]
5.61 x 41 5.62 x 2
Pre-market 5.61 -0.20 (-3.44%) 04:12 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -463,661 | -284,755 | -188,913 | -91,373 | -328,066 |
| Depreciation Amortization | 36,494 | 23,543 | 16,345 | 7,377 | 24,402 |
| Accounts receivable | -6,071 | -1,243 | -304 | -1,040 | -7,756 |
| Accounts payable and accrued liabilities | 6,435 | -1,687 | -174 | 1,168 | -987 |
| Other Working Capital | -38,001 | -44,049 | -46,715 | -36,451 | -50,257 |
| Other Operating Activity | 105,630 | 64,447 | 35,242 | 18,019 | 74,884 |
| Operating Cash Flow | $-359,174 | $-243,744 | $-184,519 | $-102,300 | $-287,780 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 480 |
| PPE Investments | -13,695 | -12,397 | -7,835 | -6,653 | -11,955 |
| Net Acquisitions | 277,104 | N/A | N/A | N/A | 1,844 |
| Purchase Sale Intangibles | -3,350 | -3,000 | -3,000 | 0 | -597 |
| Other Investing Activity | -3,350 | -3,000 | -3,000 | 0 | -597 |
| Investing Cash Flow | $260,059 | $-15,397 | $-10,835 | $-6,653 | $-10,228 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,440 | -2,339 | -52 | -26 | -766 |
| Common Stock Issued | 300,417 | 289,387 | 272,419 | 10,873 | 128,093 |
| Other Financing Activity | 8,143 | 6,433 | 4,652 | 3,050 | 12,806 |
| Financing Cash Flow | $304,120 | $293,481 | $277,019 | $13,897 | $140,133 |
| Exchange Rate Effect | -3,406 | 66 | -337 | -219 | 188 |
| Beginning Cash Position | 401,425 | 401,425 | 401,425 | 401,425 | 559,112 |
| End Cash Position | 603,024 | 435,831 | 482,753 | 306,150 | 401,425 |
| Net Cash Flow | $201,599 | $34,406 | $81,328 | $-95,275 | $-157,687 |
| Free Cash Flow | |||||
| Operating Cash Flow | -359,174 | -243,744 | -184,519 | -102,300 | -287,780 |
| Capital Expenditure | -13,695 | -12,397 | -7,835 | -6,653 | -11,955 |
| Free Cash Flow | -372,869 | -256,141 | -192,354 | -108,953 | -299,735 |